Title:
IMMUNOREGULATORY VACCINE
Document Type and Number:
WIPO Patent Application WO/2014/009209
Kind Code:
A3
Abstract:
An immune-regulatory vaccine comprising - a directed adjuvant comprising at least an anti-CD32 moiety linked to a TLR9 ligand and a first peptidic alpha-helix, and - an immunogen with at least one epitope and a second peptidic alpha-helix coiled to the first alpha-helix, a kit for preparing the vaccine, and a sensibilizing vaccine comprising at least an anti-CD32 moiety linked to a TLR9 ligand and a peptidic alpha-helix in a pharmaceutical formulation.
More Like This:
Inventors:
MUDDE GEERT (AT)
Application Number:
PCT/EP2013/063959
Publication Date:
April 17, 2014
Filing Date:
July 02, 2013
Export Citation:
Assignee:
TARGET THERAPEUTICS GMBH S (AT)
International Classes:
A61K39/00
Domestic Patent References:
WO2007098934A1 | 2007-09-07 |
Foreign References:
EP2397547A1 | 2011-12-21 |
Other References:
See also references of EP 2872169A2
Attorney, Agent or Firm:
REDL, Gerda et al. (Donau-City-Strasse 1, Vienna, AT)
Download PDF:
Previous Patent: METHOD FOR PRODUCING AQUEOUS SOLUTIONS OF COBALT SULPHATE
Next Patent: METHOD FOR INJECTING MICROPARTICLES INTO A MICROFLUIDIC CHANNEL
Next Patent: METHOD FOR INJECTING MICROPARTICLES INTO A MICROFLUIDIC CHANNEL